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Abstract
Background: In Drosophila, mutations in the gene eyes absent (eya) lead to severe defects in eye
development. The functions of its mammalian orthologs Eya1-4 are only partially understood and
no mouse model exists for Eya3. Therefore, we characterized the phenotype of a new Eya3
knockout mouse mutant.
Results: Expression analysis of Eya3 by in-situ hybridizations and β-Gal-staining of Eya3 mutant
mice revealed abundant expression of the gene throughout development, e.g. in brain, eyes, heart,
somites and limbs suggesting pleiotropic effects of the mutated gene. A similar complex expression
pattern was observed also in zebrafish embryos.
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The phenotype of young adult Eya3 mouse mutants was systematically analyzed within the German
Mouse Clinic. There was no obvious defect in the eyes, ears and kidneys of Eya3 mutant mice.
Homozygous mutants displayed decreased bone mineral content and shorter body length. In the
lung, the tidal volume at rest was decreased, and electrocardiography showed increased JT- and
PQ intervals as well as decreased QRS amplitude. Behavioral analysis of the mutants demonstrated
a mild increase in exploratory behavior, but decreased locomotor activity and reduced muscle
strength. Analysis of differential gene expression revealed 110 regulated genes in heart and brain.
Using real-time PCR, we confirmed Nup155 being down regulated in both organs.
Conclusion: The loss of Eya3 in the mouse has no apparent effect on eye development. The wide-
spread expression of Eya3  in mouse and zebrafish embryos is in contrast to the restricted
expression pattern in Xenopus embryos. The loss of Eya3 in mice leads to a broad spectrum of
minor physiological changes. Among them, the mutant mice move less than the wild-type mice and,
together with the effects on respiratory, muscle and heart function, the mutation might lead to
more severe effects when the mice become older. Therefore, future investigations of Eya3 function
should focus on aging mice.
Background
Eya3 is one of four mammalian orthologous genes (Eya1-
4) of eyes absent (eya) in Drosophila melanogaster [1,2]. Pre-
vious investigations demonstrated that a homozygous
knockout of eya  function in D. melanogaster results in
severe embryonic defects and absence of compound eyes
due to eye progenitor cell death [3,4]. Like eyes absent in
Drosophila, mammalian Eya genes encode for transcrip-
tional co-activator proteins and are widely co-expressed
with Pax6, Six1, Six2 and Dachshund (Dach) genes. It is
assumed that Eya genes are part of a hierarchically organ-
ized and highly conserved regulatory network during eye
development with Pax6 on its top and Six and Dach genes
as major players [5].
Eya proteins interact as transcriptional cofactors with Six
and Dachshund proteins and do not possess DNA-bind-
ing properties. Eya proteins are characterized by a con-
served 271-aa C-terminal domain (Eya domain, ED)
which is believed to have a dual function [6]: on one
hand, it mediates protein-protein interactions with Six
and Dachshund proteins [7,8]; it is further required for
nuclear translocation of Eya proteins [9]. On the other
hand, in-vitro experiments demonstrated a tyrosine-phos-
phatase activity of the ED suggesting a catalytic function
of this domain [10,11]. A second and far less conserved
domain is the Eya domain 2 (ED2), which is located in
the N-terminal region of the protein and presumably
serves as a transactivation domain [12].
The relevance of mutations in the ED for the emergence of
diseases has been widely shown for Eya1. In humans,
EYA1 haploinsufficiency is responsible for branchio-oto-
renal (BOR) syndrome or branchio-oto (BO) syndrome.
BOR is an autosomal dominant disorder characterized by
branchial cysts, ear malformations, hearing loss and renal
abnormalities. Interestingly, the majority of BOR disease-
associated missense mutations clusters in the ED and
therefore suggest an important role for the ED in the
development of these diseases [13]. Mice in which 153 of
271 amino acids of the Eya1-ED have been deleted die at
birth and show severe craniofacial and skeletal defects and
an absence of ears, kidneys, thymus and parathyroid
glands [14]. Eya1+/- mice show a phenotype, which is com-
parable to humans suffering from BOR syndrome. They
display renal abnormalities and conductive hearing loss.
Neither Eya1+/- nor Eya1-/- mice reveal ocular defects and
only in a few cases could Eya1 mutations be associated
with congenital cataracts and ocular anterior segment
anomalies in humans [15].
Moreover, Eya genes are associated with the proper devel-
opment of muscles. Drosophila eya mutants show muscu-
lature defects [16]; mouse embryos deficient for Eya1 and
Six1 have a complete absence of all hypaxial muscle and a
severe reduction of epaxial muscle [17]. While neither in
Eya1-/- nor in Eya2-/- mice can a muscle phenotype be
observed, Eya1-/-Eya2-/- double knockout embryos display
muscle-less limbs [18]. For Eya2 it was shown in tissue
culture experiments that it interacts with Six1 and Dach2
to regulate Pax3 and therefore to influence myogenic dif-
ferentiation [19]. In addition, Eya genes seem to play a
role in heart and auditory function in vertebrates. Muta-
tions of the EYA4 gene resulting in truncated EYA4 pro-
teins cause dilated cardiomyopathy and conductive
hearing loss in humans [20,21] and Eya4 mutations in
mice are responsible for an abnormal morphology of the
middle ear [22]. Injection of morpholino oligonucle-
otides against Eya4 into zebrafish (Danio rerio) embryos
indicated an abnormal morphological and physiological
phenotype of the heart [20]. Obviously, Eya  genes are
involved in the proper development of many tissues in
vertebrates including the ear, muscles, heart, renal system
and possibly the eye.BMC Developmental Biology 2008, 8:118 http://www.biomedcentral.com/1471-213X/8/118
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However, the influence of Eya3 on developmental proc-
esses in mice and other mammals is rather unknown. In-
vitro experiments showed that Eya3 is important for cell-
autonomous proliferation of murine myoblast C2C12
cells [17]. In addition, studies in Xenopus revealed a strong
influence of the Eya3 homologous gene Xeya3 on survival
and proliferation of neural progenitor cells in the anterior
neural plate of Xenopus embryos [23]. There are, however,
no indications for a similar expression pattern, neither in
fishes nor in mice, and we cannot observe a brain pheno-
type in our mouse Eya3 mutants. To our knowledge, this
Eya3-deficient mutant is the first mouse model for a muta-
tion affecting Eya3 and therefore an excellent model to
study its function in mammals. Our systemic analysis
within the German Mouse Clinic (GMC) demonstrated a
broad spectrum of minor physiological changes in the
Eya3-deficient mice. Among them, the reduced movement
of the mutant mice and effects on their respiratory, muscle
and heart function are the most striking changes.
Results
1. Molecular characterization of Eya3-deficient mice
Gene trap vector insertion was detected in a 16.7 kb large
intronic region of the Eya3 gene (intron 7) using 5'RACE
and PCR experiments and combining different forward
primers and a reverse primer in the lacZ cassette of the
pT1βgeo-vector. By cloning and sequencing of a 2.1 kb
fragment in this region the integration site was deter-
mined to 132.23 Mb on chromosome 4 (Ensembl data-
base, release No. 50, 2008) (Fig. 1a, 1b). Genotyping of
mice confirmed the vector integration at the determined
locus (Fig. 1c).
RT-PCR and Northern-Blotting demonstrated the com-
plete loss of exons 8–15 of the Eya3 gene in homozygous
mutant animals. Transcripts containing exons 1–8 were
detected in wild-type and heterozygous embryos at the
age of E11.5 (whole embryo), E13.5 (head) and E15.5
(head). In contrast, no transcripts covering the exons 1–8,
8–11 or 12–15 were detectable in homozygous Eya3-
mutants (Fig. 2a). Additionally, using a probe covering
exons 8–11, Northern-Blotting (RNA from E15.5) were
consistent with the results received from RT-PCR (Fig. 2b).
150 offspring from heterozygous matings have been
checked: there were 76 males (50.5%) and 74 females
(49.5%); 35 animals were wild type (23%), 85 hetero-
zygous (57%) and 30 animals homozygous mutants
(20%); the mean litter size was 5.2 offspring. These date
indicate no major deviation from the expected numbers
according to the Mendelian laws suggesting normal fertil-
ity of the heterozygotes and survival of the homozygous
mutants.
2. Expression pattern of Eya3 in the mouse and 
consequences of Eya3 invalidation
Eya3 shows a complex expression pattern during embry-
onic development. The expression pattern of Eya3 is iden-
tical, if analyzed by in-situ  hybridization in wild-type
embryos or by β-Gal expression in Eya3-/- mutant mice;
data gathered from β-Gal staining of mutant embryos
(Fig. 3a) demonstrated an expression of Eya3 at E9.5 in
the developing neural tissues predominantly in the neural
epithelium of the telencephalic vesicle and the later fore-
brain. Further on, lacZ staining is found in the somites, in
the mandibular and maxillary component of the first
branchial arch, in the optic vesicle and in the otic vesicle.
In addition, an expression in the forelimb bud is visible.
The expression of lacZ continues at the developmental
stage E10.5 in the epithelium of the telencephalic vesicle
and in tectorial regions of the developing brain. Moreo-
ver, Eya3 expression is indicated in the region surrounding
the olfactory pit, the somites, fore- and hindlimb bud and
in the trigeminal nerve. The first and second branchial
arches display Eya3/lacZ transcripts, but the expression in
the first branchial arch is mainly restricted to the mandib-
ular component. At E11.5 Eya3 expression is detectable in
the olfactory pit, the developing eye, the otic vesicle, tec-
torial and pretectorial regions of the brain, fore- and hind-
limbs and in somites. At E12.5, Eya3 transcripts are most
prominent in the limbs, in the tail and in cortical regions
of the brain. Later (E13.5), the expression of Eya3 contin-
ues in the cerebellar cortex and in the limbs as well as in
the ventral and dorsal grey horn of the spinal cord (not
shown).
Eya3 expression in the eye (Fig. 3b) is first visible at E10.5
in the detaching lens vesicle. Later on transcripts are
restricted to the retina and the lens epithelium (E15.5 –
E17.5). In adult mice (Fig. 3c), an expression of Eya3 was
traceable by RT-PCR in the brain, skeletal muscles, heart
and kidneys. The lung displayed only a very weak Eya3
expression, while in the liver no expression was detected.
3. Eya3 expression in zebrafish development
Because of the obvious strong difference in the Eya3
expression pattern between mouse and Xenopus, we inves-
tigated Eya3 expression also in zebrafish embryos. Like at
early developmental stages in mice, whole mount in-situ
hybridization revealed a ubiquitous expression of eya3 in
early zebrafish embryos throughout gastrulation and early
somitogenesis. At the 10-somite-stage (14 hours post-fer-
tilization, hpf), expression becomes more restricted to the
anterior part of the embryo and at the 20-somite-stage (19
hpf) it is most prominent in the brain and developing eye.
By the beginning of the second day of development (28
hpf),  eya3  expression strongly decreases and becomesBMC Developmental Biology 2008, 8:118 http://www.biomedcentral.com/1471-213X/8/118
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only weakly detectable in the eye, optic tectum and olfac-
tory placode (Fig. 4).
4. General characterization of the Eya3-/- phenotype
In cooperation with the German Mouse Clinic [24] 24
wild-type controls (14 , 10 ) and 24 Eya3-/- mice (14
, 10 ) have been analyzed in a comprehensive pheno-
typic screen.
Eya3 mutant animals have been investigated for bone-
and weight-related quantitative parameters at the age of
18 weeks. Among these parameters, the homozygous Eya3
mutants showed significant differences in bone mineral
content, body weight and body length as compared to the
control littermates. At the age of 18 weeks, these three
parameters were significantly (p < 0.05) reduced in male
mutants. Female mutants also displayed lower values
compared to wild-type animals without reaching the level
of statistical significance (table 1).
Data from expression analysis demonstrated that Eya3 is
expressed in the developing ear and in the adult kidney.
However, no significant differences between Eya3 knock-
out and wild-type animals have been observed in either
functional or histological analyses, suggesting that Eya3 is
not a major player in these organs. Moreover, expression
analysis displayed that Eya3 is expressed in the retina and
in the lens epithelium of the eye (Fig. 3b), suggesting that
Generation of Eya3-deficient mice by insertional mutagenesis Figure 1
Generation of Eya3-deficient mice by insertional mutagenesis. (a) Schematic illustration of the gene trap vector inte-
gration into intron 7 of the Eya3 gene resulting in a loss of the following exons. (b) Sequence fragment of the Eya3 gene. The 
upper chromatogram displays the sequence of wild-type mice, while the lower chromatogram shows the vector integration in 
mutant mice at 132.23 Mb on chromosome 4 (Ensembl database, release No. 50, 2008). (c) Eya3 mutant mice were genotyped 
by triplex PCR with a genomic forward primer combined with a genomic reverse primer for identification of wild-type animals 
and with a reverse primer within the gene trap vector for identification of homozygous mutant animals.
wild type
Eya3-/-
ATCCTCCTGCCTCTACTTCTCAGATGCTGGGGTAGCAGGCATGTGCC
ATCCTCCTGCCTCTACTTCTCAGGTCCTCTTTCCCAGGGAGGGAAGGA
ATCCTCCTGCCTCTACTTCTCAGATGCTGGGGTAGCAGGCATGTGCC
ATCCTCCTGCCTCTACTTCTCAGGTCCTCTTTCCCAGGGAGGGAAGGA *********************
(a)
(b)
132.28 Mb 3´
Isoform 1
Isoform 2
Isoform 3
chr. 4: 132.19 Mb 5´
Eya3
Insertion
ex 1
ex 1
ex 1
501 bp
692 bp
m
a
r
k
e
r
E
y
a
3
-
/
-
E
y
a
3
-
/
-
E
y
a
3
+
/
-
w
i
l
d
 
t
y
p
e
(c)
2 3     4        5    6   7                              8    9 10   11 12 13  14  15 16      17   18
2                  5    6                                   8   9 10   11 12 13  14  15 16      17   18
2        4        5    6   7                              8    9 10   11 12 13  14  15 16      17   18BMC Developmental Biology 2008, 8:118 http://www.biomedcentral.com/1471-213X/8/118
Page 5 of 18
(page number not for citation purposes)
Eya3 may be important for proper lens and retina devel-
opment. However, histological analysis of eyes taken
from adult mice revealed no morphological differences
between wild-type controls and homozygous Eya3
mutant mice (Fig. 5a, b). Further on, the investigation of
the posterior part of the eye by funduscopy (Fig. 5c) did
not show striking phenotypical differences of the retinal
structure between wild-type and mutant animals. In addi-
tion to the morphological examination of the retina a
rough functional analysis was done by electroretinogra-
phy (ERG) (Fig. 6a). Measurement of retinal and ganglion
cell response to the light stimulus displayed no significant
(p > 0.05) deviations in mutant animals compared to
wild-type controls.
An investigation of the eye size by laser interference
biometry  was performed to identify eye size variation
between wild-type controls and Eya3 mutant animals (Fig.
6b). Anterior chamber depth, lens size and axial length
were measured revealing no significant (p > 0.05) devia-
tions between wild-type mice and homozygous Eya3
mutant mice.
Alteration in lung, heart and muscle function
The expression analysis (Fig. 3) demonstrated that Eya3 is
expressed in heart and muscle, but only weakly in the
lung. Nevertheless, systematic analysis of the function of
these three organ systems showed significant alterations.
To evaluate the lung function, several parameters have
been tested in male Eya3-/- mutants and compared to wild-
type littermates (tidal volumes, respiratory rates, minute
ventilation, inspiratory and expiratory times as well as
peak inspiratory and peak expiratory flow rates). Among
these parameters, the tidal volume at rest is significantly
reduced (p < 0.05) in the mutants (+/+: 0.25 ± 0.01 ml, n
= 5; Eya3-/-: 0.22 ± 0.01 ml, n = 4). This difference is more
striking (p < 0.02), if related to the body weight (+/+: 10.1
± 0.3 μl/g, n = 5; Eya3-/-: 8.7 ± 0.3 μl/g, n = 4). In this con-
text, it might be of interest that the respiratory rate of the
mutant mice is enhanced, even if it does not reach the
level of statistical significance (+/+: 302.2 ± 9.3/min, n =
5; Eya3-/-: 342.6 ± 19.1/min, n = 4). However, this may
suggest that compensatory mechanisms are triggered. The
reduced muscle strength – if transferable to respiratory
muscles – may limit the potential volume to be inspired
and, thus, result in the observed reduced tidal volume.
Consequently, the respiratory rate is increased leading to
strikingly similar minute ventilations in wild type and
Eya3-/- (72.7 ± 3.5 ml/min vs. 71.0 ± 1.6 ml/min).
In addition, cardiovascular function was examined by
tail-cuff blood pressure and by electrocardiography
(ECG). Analysis of blood pressure revealed no genotype-
specific differences between wild-type and mutant mice.
In contrast, the ECG showed significant genotype-specific
differences between controls and mutants of both sexes
(Fig. 7). The time from onset of the electrical impulse in
the sinu-atrial node until ventricular depolarization (PQ-
interval) was increased. Additionally, the time from ven-
tricular depolarization to repolarization (JT-interval) was
extended, and the amplitude of the QRS-complex repre-
Mutation of Eya3 causes a loss of exons 8 – 15 in homozygous mutants Figure 2
Mutation of Eya3 causes a loss of exons 8 – 15 in homozygous mutants. (a) RT-PCR with cDNA of wild type and 
Eya3-/- embryos at developmental stages E11.5 (whole embryo), E13.5 (head), E15.5 (head) showed the loss of exons 8 – 15 of 
the Eya3 gene in Eya3-/- mice. (b) Northern-Blotting using RNA of wild-type and Eya3-/- embryos (E15.5) with a riboprobe 
against exons 8 – 11 confirmed the data received from RT-PCR.
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Expression pattern of Eya3 in mice Figure 3
Expression pattern of Eya3 in mice. (a) Expression analysis of Eya3 by lacZ-staining in homozygous Eya3-/- embryos (A – E, 
E9.5 – E13.5) revealed an expression of Eya3 in specific regions including the eyes, limbs, somites, branchial arches, tectorial 
regions, and in different areas of the developing brain. Since the expression pattern of Eya3 is identical, if analyzed by in-situ 
hybridization in wild-type embryos or by β-Gal expression in Eya3-/- mutant mice, only the mutant data are shown. Wild-type 
embryos as negative controls did not show lacZ-staining (F). (Ba, branchial arches; Ey, eye; Ea, ear; Fl, forelimb; FlB, forelimb 
bud; H, heart; Hl, hindlimb; HlB, hindlimb bud; OlP, olfactory pit; Ol, olfactory region; Ov, optic vesicle; OtV, otic vesicle; Pt, 
pretectorial region; So, somites; Tc, tectorial region; Ta, tail; Te, telencephalon; TeV, telencephalic vesicle; Tg, trigeminal nerve; 
Wf, follicle of whiskers). (b) Expression analysis of Eya3 in the eye with in-situ hybridization displayed transcripts in the detach-
ing lens at E11.5 and afterwards in the lens epithelium and in the retina (E15.5 – E17.5) (L, lens; Le, lens epithelium; Lfc, lens 
fiber cells; Lv lens vesicle; R, retina; On, optic nerve). (c) RT-PCR with cDNA of adult mice showed an Eya3 expression in mus-
cle, heart, brain, kidney and lung, however, no Eya3 transcript was found in the liver.
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senting ventricular depolarization was highly significantly
decreased in mutant animals (table 2).
For evaluation of the behavioral phenotype, the sponta-
neous activity of mice was measured using a modified
hole-board test. The mutants demonstrated a mild
increase in exploratory behavior as indicated by a reduced
latency to hole exploration. The frequency of rearings in
the box was also enhanced in the mutants. However, the
difference did not reach the level of statistical significance.
In contrast, mutant mice exhibited a reduced forward
locomotor activity, measured as reduced distance travel,
reduced maximum velocity and reduced frequency of
turns; the mean velocity was also reduced, but the differ-
ence did not reach the level of significance (table 3). The
reduced locomotor activity might be associated with
reduced muscle strength in these mice as indicated by the
results of the forelimb grip strength test: Eya3 mutant mice
of both sexes revealed a significant (p < 0.05) reduction of
muscle strength. However, the performance on the
Rotarod was only slightly impaired and did not reach the
level of statistical significance.
Analysis of differentially expressed genes in Eya3 mutant mice
Since the members of the Eya gene family are discussed to
be members of a conserved regulatory network during eye
development including also Six and Dach genes and Pax6
on its top [5], we tested the influence of the loss of Eya3
activity on their expression. Fig. 8a demonstrates that all
six Six genes as well as the two Dach genes are not changed
in their overall expression at least within the critical phase
of early eye development between E11.5 and E15.5. On
the other side, we checked also the Eya3 expression in two
Pax6  mutant alleles (Fig. 8b; allele symbols Aey11,
ADD4802; 39); the overall Eya3 expression is obviously
not altered even in homozygous Pax6 mutant embryos.
The same is true in a Pitx3 mutant aphakia (allele symbol
ak; Fig. 8c; [25]). These results indicate that Eya3 is no
major player in the regulatory network of eye develop-
ment.
To obtain a systematic overview on the expression of
downstream target genes, we performed an expression
profiling analysis using a genome-wide cDNA microarray
approach. Gene expression patterns of skeletal muscle,
heart, and brain of adult, homozygous Eya3 mutants were
compared to wild-type littermates. In skeletal muscles of
Eya3 mutant mice no significantly regulated genes were
detected between mutant and wild-type tissue. In contrast,
93 differentially expressed genes were identified in brain
(13 up- and 80 down-regulated genes; Fig. 9a). In heart
tissue all 17 differentially regulated genes showed
Whole-mount in-situ hybridization for eya3 expression in zebrafish embryos Figure 4
Whole-mount in-situ hybridization for eya3 expression in zebrafish embryos. Whole-mount in-situ hybridization for 
eya3 expression in zebrafish embryos reveals a ubiquitous expression of eya3 throughout gastrulation and early somitogenesis 
(A-F). Cross sections at the tailbud stage (level indicated in C) confirm expression in all cell layers (D), compared to a hybridi-
zation using the sense probe (E). The expression is more restricted to the anterior part of the embryo at 14 hpf (G). From 19 
hpf the expression is most prominent in the developing brain and eye (H). By the beginning of the second day (28 hpf) (I) eya3 
expression strongly decreases and is only weakly detectable in the eye, optic tectum, tegmentum and olfactory placode. This is 
confirmed on cross sections (J, L, at the levels indicated in I) compared to hybridization with the sense probe (K, M). Abbrevi-
ations: ap, animal pole; e, eye; l, lens; ot, optic tectum; olf, olfactory placode; r, retina; s, shield; tb, tailbud; teg, tegmentum.BMC Developmental Biology 2008, 8:118 http://www.biomedcentral.com/1471-213X/8/118
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decreased expression levels in the Eya3 mutant mice (Fig.
9b). Due to the limited number of regulated genes, no
over-representation of Gene Ontology (GO) terms could
be identified in these 17 genes. However, among the dif-
ferentially regulated genes in the brain, the macromole-
cule biosynthetic process was over-represented for
biological processes, and the structural constituent of
cytoskeleton and structural constituent of ribosome were
over-represented for molecular functions.
Among these differentially regulated genes, Nup155
(Nucleoporin 155) was significantly down-regulated both,
in heart (2.1-fold) and  brain (2.8-fold). Validation of
Nup155 expression level with real-time PCR confirmed
the differential regulation in both organs of the Eya3-/-
mutant mice (heart: 1.6-fold, p < 0.05; brain: 2.2-fold, p <
0.01). Since the Nup155 protein is discussed to be
involved in the transport of proteins and mRNA, its
reduced expression in brain and heart might also contrib-
ute to the alterations observed in the behavioral pheno-
type of the Eya3 mutant mice and of their slightly altered
cardiac function.
Discussion
The gene eyes absent was shown to have a prominent func-
tion during eye development of Drosophila melanogaster
[3]. In contrast, the mammalian orthologs seem to play a
far less important role in eye development.
In contrast to Xenopus embryos, where the expression of
Xeya3 is restricted exclusively to the anterior neural plate
and cells of the prospective brain and eye within neurula-
tion (Kriebel et al., 2007), our results from mice and
zebrafish display a ubiquitous expression of Eya3 in early
embryos during neural plate stage. It is only by the end of
neurulation that a restriction of Eya3 expression to dis-
tinct regions like forebrain and eye in mice or optic tectum
and eye in zebrafish is observable. Thus, our expression
analysis for Eya3 in mouse and zebrafish demonstrates
striking differences between these organisms and Xenopus,
suggesting the possibility of different functions for Eya3
among vertebrate species.
This might be due to differences in regulatory mecha-
nisms of Eya3  between these organisms. Comparative
sequence analysis of the Eya3  upstream region using
mVISTA (Fig. 10) revealed a significantly higher number
of conserved non-coding sequences (CNS) between
mouse and zebrafish than between mouse and Xenopus
(mouse ↔ zebrafish: 13 CNS, 1325 bp at 52,9%; mouse
↔ Xenopus: 1 CNS, 78 bp, 50%), indicating the possibility
that Eya3 genes gained individual expression patterns and
functions among vertebrate species due to evolutionary
determined diversity in regulatory mechanisms.
The results of our phenotypic study on Eya3 are in line
with earlier findings in other mammalian Eya genes indi-
cating that their loss does not have an effect on eye devel-
opment and ocular functions. Eye disorders have not been
observed in Eya1, Eya2 or Eya4 mutant mice [14,18,22].
Additionally, histological analysis and detailed investiga-
tion of ocular morphology and function by tests such as
electroretinography and the optokinetic reflex in the Eya3
knockout mutants presented here did not show any differ-
ences between the eyes of wild-type controls and hetero-
or homozygous Eya3 mutant animals, although expres-
sion of Eya3 was detected in the retina and in the lens epi-
thelium during eye development. In addition to the
striking differences between the function of Eya genes in
Drosophila and mice, there are also important differences
between the phenotypes of Eya  mutants among verte-
brates. In contrast to morpholino-injected Xenopus
embryos [23], Eya3 mutant mice showed a normal devel-
opment of neural tissues.
Nevertheless, further investigations revealed clear differ-
ences in bone mineral content and body length between
wild-type animals and Eya3 mutant mice, suggesting an
impact of Eya3 on physical constitution in general, lead-
ing to a reduction of growth. Moreover, Eya3 is expressed
in the developing muscle, and concomitantly, the fore-
limb grip strength is reduced in the mutant mice. This
might be a reason for the observed decreased locomotor
activity of the Eya3 mutant mice. Muscle deficiencies have
been reported also for Eya1-/-Eya2-/- mutant mice [18], and
also for Six1, encoding a potential interaction partner of
Table 1: Bone- and weight-related quantitative parameters (18 week old mice)
Wild type Eya3-/-
male female male female
Parameter n = 9 n = 9 n = 10 n = 9
Bone mineral content [mg] 557 ± 33 467 ± 21 422 ± 39* 447 ± 33
Body length [cm] 9.06 ± 0.06 8.89 ± 0.07 8.60 ± 0.15* 8.67 ± 0.08
Body weight [g] 27.29 ± 0.63 21.05 ± 0.44 23.96 ± 1.12* 20.57 ± 0.82
*p < 0.05 (as compared to the corresponding group of wild-type mice); data are presented as mean ± standard error of the meanBMC Developmental Biology 2008, 8:118 http://www.biomedcentral.com/1471-213X/8/118
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Eya proteins, which is also required for proper muscle
development [26].
Moreover, the results from additional physiological inves-
tigations indicate that Eya3 mutant mice suffer also from
some heart and lung problems as indicated by some ECG
parameters (increased PQ and JT intervals, decreased QRS
amplitude) and a decreased tidal volume of the lung.
Indeed, Eya4 is also involved in cardiac processes as dem-
onstrated previously in human and zebrafish [20]. Taking
the lung, heart and muscle alterations together, the signif-
icantly reduced locomotion might be understood as a
consequence of all these features. Since we have tested the
mice only at a young age, these deficits might accumulate
during ageing and therefore be responsible for more
severe deficits when the mice become older.
To understand the molecular network involving Eya3, we
analyzed differentially expressed genes in the mutants. We
identified several regulated genes in heart and brain indi-
cating regulatory effects of the Eya3 mutation or second-
ary affects based upon missing or changed cell types.
Among them, Nup155 was confirmed by real-time PCR to
be significantly down-regulated in both organs. Nup155 is
involved in nuclear envelope formation during cell divi-
sion and is important for the export of macromolecules
like mRNAs from the nucleus to the cytoplasm. Depletion
of Nup155 leads to a failure of nuclear lamina formation
and defects in chromosome segregation at anaphase [27]
and therefore has an important impact on cell prolifera-
tion. Nup155 encodes a protein containing nucleoporin, a
non-repetitive/WGA-negative domain. Gene ontology
(GO) terms indicate that Nup155 protein is located in a
nuclear pore and in a membrane.
Among the 17 down-regulated genes in the heart of Eya3
mutant mice, some are associated with specific cardiac
functions, e.g. Tnnc1 is involved in cardiac muscle con-
traction,  Calm3  plays a role in calcium signaling, and
Ankrd1 is a transcriptional co-factor being required during
cardiac myogenesis [28,29].
Furthermore, for several regulated genes in the brain an
association with neurodegeneration, particularly with
Alzheimer disease has been found. Among the up-regu-
lated genes, ASS1  expression levels were significantly
higher in glial cells of Alzheimer's disease brains [30].
Among the genes being down-regulated in the brains of
Eya3 mutants, several are reported to be down-regulated
also in Alzheimer's disease, e.g. ARPP19 [31], BIRC4 [32],
MT3 [33], SYT1 [34] or TTR [35]. Moreover, the SCA10
gene, which is down-regulated in the brain of the Eya3
mutants, is also down-regulated in patients suffering from
Parkinson's disease [36]. This short comparison between
the differentially expressed genes in the Eya3 mutant mice
with corresponding features in neurodegenerative disor-
ders in human patients points to an interesting putative
role of EYA3 in Alzheimer's and Parkinson's disease. This
function might be attributed by putative interaction of
Eya3 with either Six1 (Six1 binding sites were reported in
the Birc4 promoter) or with Pax6 (Pax6 binding sites have
been identified in the Ass1 promoter) (data accumulated
by Bibliosphere). These functional considerations are
based upon associative interpretations of available litera-
ture and comparison with the data obtained during the
basic characterization of the Eya3 mutant opening several
interesting avenues for further detailed experimental stud-
ies.
Conclusion
Our study demonstrates that Eya3  affects particularly
heart, lung and muscle functions. Even if the exploratory
behavior is increased, the mutant mice move less than the
wild-type mice. Together with the effects on respiratory,
muscle and heart function, it might lead to more severe
effects, when the mice become older. Therefore, future
investigations of Eya3 function should focus on effects on
aging mice and consider also effects related to neurode-
generative disorders like Alzheimer's or Parkinson's dis-
ease.
Histology and funduscopy of the eye in Eya3 mouse mutants Figure 5
Histology and funduscopy of the eye in Eya3 mouse 
mutants. (a) Histology of the eye showed no morphological 
differences between wild-type mice and homozygous 
mutants (C, cornea; L, lens; R, retina). In line with these 
results histological analysis (b) and funduscopy (c) of the ret-
ina could not detect structural impairments in mutant ani-
mals (GCL, ganglion cell layer; IPL, inner plexiform layer; INL, 
inner nuclear layer; OPL, outer plexiform layer; ONL, outer 
nuclear layer; RPE retinal pigment epithelium).
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Methods
Generation and molecular characterization of Eya3 
mutant mice
The Eya3  deficient mouse line was generated by inser-
tional mutagenesis in a large-scale gene trap screen (Ger-
man Gene Trapping Consortium, GGTC). A promoterless
reporter gene (lacZ) was inserted into the mouse genome
by random integration of a gene trap vector (pT1βgeo)
[37]. ES cells were derived from strain Sv129S2 (formerly
known as Sv129Pasteur). Mutant mice were generated
through blastocyst injection and resulting chimeras were
bred to C57BL/6 females and crossed to C57BL/6 for four
generations. Thus, mice were predominantly C57BL/6. All
experiments and housing of the animals were performed
according to the German Law on the Protection of Ani-
mals (regulation 209.1/211-2531-112/02 by the Govern-
ment of Upper Bavaria [Regierung von Oberbayern]).
For detection of the gene trap vector integration in mutant
mice a genomic forward primer was combined with a
reverse primer in the lacZ cassette of the gene trap vector.
Genotyping of mice was performed by Triplex-PCR. A
genomic forward primer was either combined with a
genomic reverse primer for wild-type amplification or
with a reverse primer within the gene trap vector for
mutant amplification (table 4). PCR was carried out using
the following cycles: 1 × 3 min 94°C; 35 × 94°C 30 sec,
62°C 45 sec, 72°C 60 sec; 1 × 72°C 5 min (PCR-cycler: MJ
Research PTC-225, Bio-Rad Laboratories, Munich, Ger-
many).
Electroretinography (ERG) and laser interference biometry Figure 6
Electroretinography (ERG) and laser interference biometry. (a) The electroretinography displays no obvious devia-
tions in the shape of the a-wave (response of photoreceptor cells) and b-wave (response of bi-polar cells) between wild-type 
controls and Eya3 mutant animals. (b) Measurement of the axial length of the entire eye and of the lens size in particular did 
not reveal significant alterations in Eya3 mutant animals compared to wild-type controls.
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RNA isolation, RT-PCR and Northern blotting
Total RNA was prepared with RNA-Bee (Tel-Test Inc.,
Friendswood, TX, USA) according to the suppliers proto-
col. Tissue (50 μg each) was taken from wild-type animals
and homozygous mutants from 3 different embryonic
stages: E11.5 (whole embryo), E13.5 (head) and E15.5
(head). cDNA was generated by using Superscript II RT
(Invitrogen, Karlsruhe, Germany).
Northern Blotting was done with RNA from E15.5
embryos. Samples were initially denatured for 10 min at
68°C and loaded onto an agarose-gel (1,2%, 1 × MOPS-
buffer) and separated under denaturing conditions for 4 h
(60 V). RNA samples were blotted to Hybond-N+ mem-
brane (Amersham Biosciences, GE Healthcare-Buchler,
Braunschweig, Germany) overnight and UV-fixed. After-
wards, the membrane was prehybridized for 2 h with
CHURCH-buffer (7% SDS, 50% formamide, 5 × SSC, 2%
Roche blocking reagent, 50 mM Na2HPO4, 0,1% lauryl-
sarcosyl) and then hybridized overnight at 52°C with a
digoxigenin-labeled riboprobe (Roche Diagnostics, Man-
nheim, Germany) against exons 8 – 11 of Eya3. Hybridi-
zation was followed by washing in 2 × SSC (30 mM Na-
Citrat pH 7.0; 300 mM NaCl), 0.1% SDS for 5 min and in
0.1 × SSC, 0.1% SDS for 40 min at 52°C. After incubation
with blocking reagent in 100 mM Tris-HCl pH 9.5 and
150 mM NaCl for 30 min at 52°C the membrane was
washed in 100 mM Tris-HCl pH 9.5, 150 mM NaCl and
incubated with anti-digoxygenin antibody (Roche,
diluted 1:5000 in 100 mM Tris-HCl pH 9.5, 150 mM
NaCl) for 30 min at room temperature. Finally, the mem-
brane was stained with NBT/BCIP in 100 mM Tris-HCl pH
9.5, 100 mM NaCl, 50 mM MgCl2 for 1 h in the dark.
Electrocardiography (ECG) of wild-type and Eya3-/- mutant mice Figure 7
Electrocardiography (ECG) of wild-type and Eya3-/- mutant mice. a) Electrocardiogram of a wild-type control. b) Elec-
trocardiogram of an Eya3-/-animal is shown. Eya3 mutant mice of both sexes displayed several alterations compared to the con-
trol animals: the PQ-interval and the JT-interval are extended in mutants, while the amplitude of the QRS-complex is reduced 
in Eya3-/- animals (alterations are indicated by black arrows).
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LacZ-staining and in-situ hybridization of Eya3
LacZ-staining was performed on whole mouse embryos of
developmental stages E11.5 – E13.5. Mouse embryos
were dissected and fixed in 4% paraformaldehyde in PBS.
For staining embryos were washed three times in PBS con-
taining 0.01% Na-deoxicholate, 0.02% Non-idet P40, 5
mM EGTA (pH 8.0) and 2 mM MgCl2 after fixation. After-
wards, embryos were stained overnight at 37°C in PBS
containing 0.5 mg/ml X-gal, 2 mM MgCl2, 5 mM
K3Fe(CN)6, 5 mM K4Fe(CN)6, 0.01% Na desoxycholate,
and 0.02% NP-40 in the dark. Before postfixation in 4%
paraformaldehyde in PBS at 4°C, several wash steps were
carried out in PBS. Embryos were stored in 70% ethanol
at 4°C.
In-situ  hybridizations with paraffin sections were per-
formed to evaluate Eya3 expression in the eye. Embryos
were fixed in 4% paraformaldehyde in PBS at 4°C, dehy-
drated and embedded in Jung Histowax (Cambridge
Instruments, Nussloch, Germany). Sections (8 μm) were
cut with the RM 2065-microtome (Leica, Wetzlar, Ger-
many), mounted onto slices and treated as previously
described [38].
Analysis of zebrafish embryos
Embryos were produced by paired matings of zebrafish
(Danio rerio, AB strain), and staged in hours post-fertiliza-
tion (hpf), as described previously [39,40]. In-situ hybrid-
ization for zebrafish embryos was performed as
previously described [41]. For sectioning at the tailbud
stage, the stained embryos were cryoprotected in 15%
sucrose in phosphate buffer, embedded in 7.5% gelatin,
15% sucrose in PBS, frozen and cryostat-sectioned at 15
μm. For sectioning at the 28 hpf stage, the stained
embryos were embedded in 3% agarose and vibratome-
sectioned at 70 μm. As probe, we used an eya3  cDNA
clone generously provided by G. Nica (LMU Munich).
Phenotyping of mice
A broad phenotypical analysis of 24 wild-type controls
(14 , 10 ) and 24 Eya3-/- mice (14 , 10 ) was done
in collaboration with the German Mouse Clinic [24]. For
histological analysis of the eye 11 week old mice were sac-
rificed and eyes were removed immediately. Fixation and
staining with hematoxylin and eosin were performed
using standard-protocols. Funduscopy (age: 11 weeks)
and electroretinography (age: 11 weeks, 9 months) were
Table 2: ECG-Parameters (15 week old mice)
Wild type Eya3-/-
male female male female
Parameter n = 8 n = 9 n = 10 n = 9
PQ interval [ms] 38.6 ± 0.7 40.8 ± 0.7 41.3 ± 1.6* 43.6 ± 0.9*
P-wave duration [ms] 20.4 ± 0.6 20.4 ± 0.8 20.8 ± 0.6 21.4 ± 0.3
QRS-complex duration [ms] 9.6 ± 0.2 9.6 ± 0.2 10.0 ± 0.2 9.8 ± 0.3
QT interval [ms] 46.2 ± 1.3 41.7 ± 0.6 45.6 ± 2.1 42.7 ± 0.6
QTcorrected [ms] 40.6 ± 1.4 36.5 ± 0.5 40.1 ± 1.5 38.2 ± 0.7
RR interval [ms] 130.6 ± 3.8 130.9 ± 4.1 130.1 ± 4.9 125.2 ± 3.7
Heart rate [bpm] 463.7 ± 13.5 463.4 ± 14.2 469.1 ± 18.6 482.7 ± 13.3
JT interval [ms] 4.1 ± 0.6 3.7 ± 0.1 6.0 ± 1.1* 5.4 ± 0.4*
ST interval [ms] 36.6 ± 1.5 32.1 ± 0.6 35.6 ± 2.1 32.9 ± 0.6
Q amplitude [mV] 0.01 ± 0.00 0.02 ± 0.01 0.04 ± 0.01** 0.03 ± 0.01**
R amplitude [mV] 3.10 ± 0.18 3.16 ± 0.35 2.32 ± 0.14** 2.33 ± 0.29**
S amplitude [mV] -1.26 ± 0.22 -1.03 ± 0.16 -0.95 ± 0.14 -1.01 ± 0.16
QRS amplitude [mV] 4.35 ± 0.17 4.19 ± 0.40 3.28 ± 0.13*** 3.34 ± 0.22***
*p < 0.05; **p < 0.01; ***p < 0.001 (as compared to the corresponding group of wild-type mice); data are presented as mean ± standard error of 
the mean
Table 3: Results of behavioural observations (8–10 week old mice).
Wild type Eya3-/-
male female male female
Parameter n = 15 n = 9 n = 15 n = 9
Forward locomotor activity (total distance travelled) [cm] 3387.2 ± 124.9 3534.3 ± 115.5 3086.8 ± 126.5* 3248.6 ± 71.4*
Speed of movement (maximum velocity) [cm/sec] 62.9 ± 1.9 59.8 ± 3.2 55.0 ± 1.9* 58.2 ± 1.9*
Turns [frequency] 1714.9 ± 46.1 1776.8 ± 41.7 1610.3 ± 41.6* 1688.8 ± 39.8*
Exploratory behaviour (hole exploration) [latency] 14.6 ± 3.7 13.9 ± 3.1 8.1 ± 1.5* 8.5 ± 1.6*
Grip strength (force) [p] 121.7 ± 2.8 99.3 ± 3.7 102.8 ± 4,9** 89.9 ± 3.9**
*p < 0.05; **p < 0.01 (as compared to the corresponding group of wild-type mice); data are presented as mean ± standard error of the meanBMC Developmental Biology 2008, 8:118 http://www.biomedcentral.com/1471-213X/8/118
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Eya3 and the retinal determination network Figure 8
Eya3 and the retinal determination network. a) The expression of all six Six genes (Six1 – Six6) and the two Dach (Dach1, 
Dach2) genes have been investigated in wild-type and homozygous mutant embryos by RT-PCR using total mRNA; β-actin was 
used as loading control. b) Eya3 expression was tested in embryos of two homozygous Pax6 mutant alleles (Pax6Aey11 and 
Pax6ADD4802); β-actin was used as loading control. b) Eya3 expression was tested in embryos of a homozygous Pitx3 mutant 
allele (Pitx3ak); β-actin was used as loading control.
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Heat plots of gene expression profiles from 8 DNA microarray experiments of Eya3 mutants versus control mice Figure 9
Heat plots of gene expression profiles from 8 DNA microarray experiments of Eya3 mutants versus control 
mice. Differential gene expression was analyzed in the brain (a) and in the heart (b). One dye-flip pair represents two experi-
mental replicates of each analyzed mouse (A-D). One ArrayTAG ID is the unique probe identifier from the LION Bioscience 
clone set. Official gene symbols are given. The scale bar encodes the ratio of the fold induction; 0.7% (a) or 1.3% (b) of the ele-
ments are above the upper limit of the color range selection (red is up-regulated and green down-regulated in the Eya3 mutant 
mice).
a) b)BMC Developmental Biology 2008, 8:118 http://www.biomedcentral.com/1471-213X/8/118
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performed as described before [42]. Laser interference
biomicroscopy (age: 13 weeks; n = 6) was carried out as
previously described [43]. Data from controls and mutant
animals were compared using the Student's t-test. Tables
show mean value ± standard error of the mean (s.e.m.).
Behavioral phenotyping was done at the age of 8 weeks by
using the modified hole board test [44] and carried out as
previously described [45]. Data were statistically analyzed
using SPSS software (SPSS Inc, Chicago, USA). The fore-
limb grip strength was tested at the age of 10 weeks with
the grip strength meter system, which determines the
muscle strength of a mouse. The device exploits the ten-
dency of a mouse to grasp a horizontal metal bar while
being pulled by its tail. During the measurement the
mouse grasps a special adjustable grip (2 mm) mounted
on a force sensor. Five trials were undertaken for each
mouse within one minute. Values were presented as
means ± standard error of the mean (SEM) and analyzed
for the effects of genotype, sex and weight by fitting linear
mixed effect models.
To examine the cardiovascular phenotype a surface limb
ECG was obtained at the age of 12 – 15 weeks in anesthe-
tized mice. The complete setup was located in a faraday
cage. A shape analysis of the ECG traces was performed
using the software ECG-auto (EMKA Technologies, Paris,
France). For each animal, intervals and amplitudes were
Conserved elements in Eya3 promoter/enhancer region Figure 10
Conserved elements in Eya3 promoter/enhancer region. Sequence analysis of 5 kb upstream from Eya3 transcriptional 
start site for mouse, zebrafish and Xenopus using mVISTA (parameters: 50% sequence identity, 80 bp window length). The anal-
ysis revealed 10 conserved non-coding regions within the mouse-zebrafish alignment (sequence identity: 1325 bp at 52.9%, 
highlighted in red) and only 1 conserved non-coding region for the mouse-Xenopus alignment (sequence identity: 78 bp at 50%). 
Transcription factor binding sites of a matrix similarity of 1.000 are mentioned. TSS, transcription start site.
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Table 4: PCR primer for characterization of the insertion of the gene trap vector
Primer Sequence (5' → 3')
gene trap forward primer (genomic) TGGGATGCAAACTCGGGTCCTA
gene trap reverse primer (lacZ cassette) CAAGGCGATTAAGTTGGGTAACG
genotyping forward primer (wild type/mutant) CAGGAACAGACTGAAACCATGC
genotyping reverse primer (wild type) AGGTTGTCAGACTGGCACTTCA
genotyping reverse primer (mutant) CACGCCATACAGTCCTCTTCAC
ex 1_forward primer CAGAGTGGGTCCGTAATCGT
ex 7_reverse primer TGCCCAGGATAAGTGGTTTC
ex 8_reverse primer ATTGCAGATGAAGTGGGTATCAG
ex 8_forward primer CCAGCCTGATACCCACTTCA
ex 11_reverse primer ATACCCGTTCCAATTCACTGTC
ex 12_forward primer CCAACAGTAGTAATTGGCTCAGGT
ex 15_reverse primer ACCTCGATCTCTGCTCTGAGTCTBMC Developmental Biology 2008, 8:118 http://www.biomedcentral.com/1471-213X/8/118
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measured from five different sets of averaged beats. In
addition, the recordings were screened for arrhythmias,
including supraventricular and ventricular extrasystoles
and conduction blockages. Analysis of variance (ANOVA)
was used for multi-factorial analysis of quantitative traits
with respect to sex and genotype.
Lung function was determined by whole body plethys-
mography according to a previously described principle
[46]. For measurement a system from Buxco® Electronics
(Sharon, Connecticut, USA) was used to assess breathing
patterns in unrestrained animals by measuring pressure
changes which arise from inspiratory and expiratory tem-
perature and humidity fluctuations during breathing. The
system allows transforming pressure swings into flow and
volume signals, so that automated data analysis provides
tidal volumes, respiratory rates, minute ventilation,
inspiratory and expiratory times as well as peak inspira-
tory and peak expiratory flow rates. Measurements were
always performed between 8 a.m. and 11 a.m. to account
for potential diurnal variations in breathing.
Gene expression of putative downstream genes were ana-
lyzed using Glass cDNA-chips containing the fully
sequenced 20K cDNA mouse arrayTAG library (Lion Bio-
science, Heidelberg, Germany) [47-50]. A full description
of the probes on the microarray is available in the GEO
database under GPL4937 [51]. The expression data of
Eya3 analysis of heart, muscle and brain have been sub-
mitted to the GEO database (GSE9999). Total RNA from
brain, heart and muscle of 12 – 13 week old male animals
(5 controls, 4 mutants) was used for cDNA chip hybridi-
zation according to a modified TIGR protocol [52]. Two
chip hybridizations including a dye-swap experiment
were performed from all selected organs of each individ-
ual mutant mouse against the identical pool of the same
organ of reference RNAs. Slides were scanned with a Gene-
Pix 4000A microarray scanner (GenePix Pro 6.1 image
processing software, Axon Instruments, USA). TIGR soft-
ware package for Microarray analysis [53] including
MIDAS (Microarray Data Analysis System) was used for
normalization and SAM (Significance Analysis of Microar-
rays) [54] for the identification of significantly differen-
tially expressed genes. Genes were ranked according to
their relative difference value d(i) and selected as signifi-
cantly regulated with d(i) > 0.5. To estimate the false dis-
covery rate, false positive genes were identified by
calculating 1000 permutations of the measurements. The
selection of the top differentially expressed genes with
reproducible up- or down-regulation includes less than
10% false positives.
The commercial software tool Bibliosphere Pathway Edi-
tion (Genomatix Software GmbH, Germany) was used to
identify pathways and gene functions that were signifi-
cantly abundant among the regulated genes. Regulated
genes were filtered for two categories of Gene Ontology
terms: biological processes and molecular functions. A
statistical analysis was performed based on the relative
number of observed versus expected annotations of each
term. The z-score (> 5.0) indicates whether particular GO
annotations are over-represented in a dataset of genes.
Results from Microarray analysis were controlled by real-
time PCR for differentially expressed genes in heart and
brain with the ABI Prism 7000 Detection System (Applied
Biosystems, Darmstadt, Germany). Therefore, the identi-
cal total RNA as for the microarray experiments was used.
Afterwards, cDNA was prepared with the Ready-to-go T-
primed First-strand Kit (Amersham Biosciences, Braun-
schweig, Germany) according to the manufacturers proto-
cols. Results from real-time PCR were analyzed with the
ABI Prism 7000 SDS software and REST (Relative Expres-
sion Software Tool [55]).
Sequence Comparison
For sequence comparison of the 5 kb upstream of the Eya3
transcription start sites we used the program mVISTA
(http://genome.lbl.gov/vista/mvista/about.shtml[56])
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